• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

204 个国家和地区 1990-2019 年胃食管反流病负担:2019 年全球疾病负担研究的系统分析。

Burden of gastroesophageal reflux disease in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of disease study 2019.

机构信息

Division of Gastroenterology and Hepatology, NHC Key Laboratory of Digestive Disease, Ministry of Health, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, 200125, China.

State Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, China.

出版信息

BMC Public Health. 2023 Mar 29;23(1):582. doi: 10.1186/s12889-023-15272-z.

DOI:10.1186/s12889-023-15272-z
PMID:36978027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10053627/
Abstract

INTRODUCTION

For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.

METHODS

The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated.

RESULTS

Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels.

CONCLUSION

GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates.

摘要

简介

为了制定有效的胃食管反流病(GORD)预防策略,我们评估了 1990 年至 2019 年期间 GORD 的负担。

方法

我们在全球、地区和国家层面评估了 1990 年至 2019 年 GORD 的负担。使用年龄标准化发病率(ASIR)和年龄标准化残疾生存年数(ASYLDs),我们将其与全球每 10 万人的 GBD 人口进行了比较。这些估计是基于 95%的不确定性区间(UI)。我们还估计了发病率、残疾生存年数(YLDs)以及患病率的平均年变化百分比(AAPC),并提供了相关的 95%置信区间(CI)。

结果

目前为止,用于评估 GORD 负担的数据还很有限。2019 年全球 GORD 的 ASIR 为每 10 万人 3792.79 例,1990 年至 2019 年的 AAPC 增加了 0.112%。GORD 的患病率呈上升趋势,AAPC 为 0.096%,达到每 10 万人 9574.45 例。2019 年全球 ASYLDs 为 73.63,1990 年至 2019 年的 AAPC 增加了 0.105%。GORD 负担因发展水平和地理位置的不同而有很大差异。美国在 GORD 负担方面表现出最明显的下降趋势,而瑞典则呈上升趋势。分解分析表明,GORD YLDs 的增加主要是由人口增长和老龄化导致的。社会人口指数(SDI)与 GORD 负担呈负相关。前沿分析显示,各级发展水平都有显著的改善空间。

结论

GORD 是一个公共卫生挑战,尤其是在拉丁美洲。一些 SDI 五分位数的发病率呈下降趋势,而一些国家的发病率呈上升趋势。因此,应根据具体国情评估结果,为预防措施分配资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e952/10053627/8232c91164c3/12889_2023_15272_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e952/10053627/250cc29d5a9f/12889_2023_15272_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e952/10053627/d90b48389b87/12889_2023_15272_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e952/10053627/8232c91164c3/12889_2023_15272_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e952/10053627/250cc29d5a9f/12889_2023_15272_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e952/10053627/d90b48389b87/12889_2023_15272_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e952/10053627/8232c91164c3/12889_2023_15272_Fig3_HTML.jpg

相似文献

1
Burden of gastroesophageal reflux disease in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of disease study 2019.204 个国家和地区 1990-2019 年胃食管反流病负担:2019 年全球疾病负担研究的系统分析。
BMC Public Health. 2023 Mar 29;23(1):582. doi: 10.1186/s12889-023-15272-z.
2
Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study.全球、区域和国家胃食管反流病负担,1990-2019 年:来自 GBD 2019 研究的更新。
Ann Med. 2022 Dec;54(1):1372-1384. doi: 10.1080/07853890.2022.2074535.
3
The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990 年至 2017 年全球 195 个国家和地区胃食管反流病的全球、区域和国家负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):561-581. doi: 10.1016/S2468-1253(19)30408-X. Epub 2020 Mar 13.
4
Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019.全球椎体骨折的发病率、患病率和残疾负担:2019 年全球疾病负担研究的系统分析。
Spine J. 2022 May;22(5):857-868. doi: 10.1016/j.spinee.2021.12.007. Epub 2021 Dec 11.
5
Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.全球、地区和国家子宫纤维瘤发病率、患病率和残疾生存年数的时间趋势,1990-2019 年:对 2019 年全球疾病负担研究的年龄-时期-队列分析。
BMC Public Health. 2023 May 19;23(1):916. doi: 10.1186/s12889-023-15765-x.
6
The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.2000 年至 2019 年全球 204 个国家和地区良性前列腺增生的全球、区域和国家负担:2019 年全球疾病负担研究的系统分析。
Lancet Healthy Longev. 2022 Nov;3(11):e754-e776. doi: 10.1016/S2666-7568(22)00213-6. Epub 2022 Oct 20.
7
Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.测量 194 个国家多囊卵巢综合征的全球疾病负担:2017 年全球疾病负担研究。
Hum Reprod. 2021 Mar 18;36(4):1108-1119. doi: 10.1093/humrep/deaa371.
8
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年食管痛的全球、区域和国家负担及其可归因风险因素:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597. doi: 10.1016/S2468-1253(20)30007-8. Epub 2020 Apr 1.
9
Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990-2019.多囊卵巢综合征在 204 个国家和地区的流行率、发病率和残疾生存年数,1990-2019 年。
Hum Reprod. 2022 Jul 30;37(8):1919-1931. doi: 10.1093/humrep/deac091.
10
Epidemiology and burden of pelvic fractures: Results from the Global Burden of Disease Study 2019.骨盆骨折的流行病学与负担:2019年全球疾病负担研究结果
Injury. 2023 Feb;54(2):589-597. doi: 10.1016/j.injury.2022.12.007. Epub 2022 Dec 9.

引用本文的文献

1
Mendel randomization confirmed gastroesophageal reflux disease may increase the risk of mental disorders.孟德尔随机化研究证实,胃食管反流病可能会增加患精神障碍的风险。
Neuropsychiatr. 2025 Aug 28. doi: 10.1007/s40211-025-00546-2.
2
Association of gastroesophageal reflux disease with the incidence of pulmonary disease.胃食管反流病与肺部疾病发病率的关联
Front Cell Dev Biol. 2025 Jul 23;13:1552126. doi: 10.3389/fcell.2025.1552126. eCollection 2025.
3
Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000-2021.

本文引用的文献

1
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review.AGA 临床实践更新:用于 Barrett 食管监测和筛查的新技术和创新:专家综述。
Clin Gastroenterol Hepatol. 2022 Dec;20(12):2696-2706.e1. doi: 10.1016/j.cgh.2022.06.003. Epub 2022 Jul 3.
2
Gastro-oesophageal reflux disease.胃食管反流病。
Nat Rev Dis Primers. 2021 Jul 29;7(1):55. doi: 10.1038/s41572-021-00287-w.
3
Gastroesophageal Reflux Disease: A Review.胃食管反流病:综述。
2000 - 2021年芬兰食管鳞状细胞癌和腺癌的发病率趋势。
Acta Oncol. 2025 Aug 1;64:1014-1020. doi: 10.2340/1651-226X.2025.44097.
4
Global, regional, and national burden of gastroesophageal reflux disease (1990-2021): age-period-cohort analysis and Bayesian projections.全球、区域和国家层面的胃食管反流病负担(1990 - 2021年):年龄-时期-队列分析及贝叶斯预测
Front Public Health. 2025 Jul 9;13:1576527. doi: 10.3389/fpubh.2025.1576527. eCollection 2025.
5
EsoDetect: computational validation and algorithm development of a novel diagnostic and prognostic tool for dysplasia in Barrett's esophagus.EsoDetect:一种用于巴雷特食管发育异常的新型诊断和预后工具的计算验证与算法开发
PeerJ. 2025 Jul 3;13:e19613. doi: 10.7717/peerj.19613. eCollection 2025.
6
Clinical diagnostic value of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for distinguishing functional heartburn from non-erosive reflux disease.平均夜间基线阻抗和反流后吞咽诱发蠕动波指数对鉴别功能性烧心与非糜烂性反流病的临床诊断价值
Prz Gastroenterol. 2025;20(2):206-214. doi: 10.5114/pg.2024.142910. Epub 2024 Sep 12.
7
Opioid analgesics for sedation-based gastrointestinal endoscopy.用于基于镇静的胃肠内镜检查的阿片类镇痛药。
World J Gastrointest Pharmacol Ther. 2025 Jun 5;16(2):102098. doi: 10.4292/wjgpt.v16.i2.102098.
8
Novel Technique to Diagnose Gastroesophageal Reflux Disease.诊断胃食管反流病的新技术
Korean J Helicobacter Up Gastrointest Res. 2024 Sep;24(3):208-217. doi: 10.7704/kjhugr.2024.0020. Epub 2024 Sep 9.
9
The prevalence of gastric reflux symptoms in Saudi Arabian statin-users, and associated factors: a tertiary-center cross-sectional observational study.沙特阿拉伯他汀类药物使用者胃反流症状的患病率及相关因素:一项三级中心横断面观察性研究。
Ann Med Surg (Lond). 2025 Apr 10;87(6):3136-3142. doi: 10.1097/MS9.0000000000003244. eCollection 2025 Jun.
10
Diagnostic accuracy of mean nocturnal basal impedance and other complementary tests for the diagnosis of gastroesophageal reflux disease according to the new Lyon criteria.根据新的里昂标准,平均夜间基础阻抗及其他补充检查对胃食管反流病诊断的准确性
Therap Adv Gastroenterol. 2025 May 22;18:17562848251340495. doi: 10.1177/17562848251340495. eCollection 2025.
JAMA. 2020 Dec 22;324(24):2536-2547. doi: 10.1001/jama.2020.21360.
4
Advances in the diagnosis and management of gastroesophageal reflux disease.胃食管反流病的诊断和治疗进展。
BMJ. 2020 Nov 23;371:m3786. doi: 10.1136/bmj.m3786.
5
Mucosal pathogenesis in gastro-esophageal reflux disease.胃食管反流病的黏膜发病机制。
Neurogastroenterol Motil. 2020 Dec;32(12):e14022. doi: 10.1111/nmo.14022. Epub 2020 Oct 28.
6
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
7
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
8
Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis.全球胃食管反流病(GORD)的患病率和危险因素:系统评价与荟萃分析。
Sci Rep. 2020 Apr 2;10(1):5814. doi: 10.1038/s41598-020-62795-1.
9
The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990 年至 2017 年全球 195 个国家和地区胃食管反流病的全球、区域和国家负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):561-581. doi: 10.1016/S2468-1253(19)30408-X. Epub 2020 Mar 13.
10
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数:1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.